Evidence map›Paper›PMID 35523763›Full record

ArticleTranslational psychiatry2022

Bayesian causal network modeling suggests adolescent cannabis use accelerates prefrontal cortical thinning.

Max M Owens, Matthew D Albaugh, Nicholas Allgaier, Dekang Yuan, Gabriel Robert, Renata B Cupertino, Philip A Spechler, Anthony Juliano, Sage Hahn, Tobias Banaschewski and 24 more

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Psychological Interventions for Cannabis Use among Adolescents and Young Adults: A Systematic Review.International journal of environmental research and public health · 2023
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Independent brain cortical signatures of risk for adolescent cannabis use and consequences of such use are moderated by sex.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Cells and Molecules Underpinning Cannabis-Related Variations in Cortical Thickness during Adolescence.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  11. Review
  12. Article
  13. Consequences of adolescent drug use.Translational psychiatry · 2023
    Review
  14. Nasal accumulation and metabolism of ΔPharmacological research · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 18 institutions in 8 countries.

Max M OwensDepartment of Psychiatry, University of Vermont Larner College of Medicine, Burlington, VT, USA. owensmax03@gmail.com.ORCID 0000-0002-5560-4077
Matthew D AlbaughDepartment of Psychiatry, University of Vermont Larner College of Medicine, Burlington, VT, USA.
Nicholas AllgaierDepartment of Psychiatry, University of Vermont Larner College of Medicine, Burlington, VT, USA.ORCID 0000-0002-9498-0200
Dekang YuanDepartment of Psychiatry, University of Vermont Larner College of Medicine, Burlington, VT, USA.
Gabriel RobertPsychiatry Department, University of Rennes 1, Rennes, France.
Renata B CupertinoDepartment of Psychiatry, University of Vermont Larner College of Medicine, Burlington, VT, USA.
Philip A SpechlerLaureate Institute for Brain Research, Tulsa, OK, USA.ORCID 0000-0003-3833-7672
Anthony JulianoDepartment of Psychiatry, University of Vermont Larner College of Medicine, Burlington, VT, USA.ORCID 0000-0001-7433-6891
Sage HahnDepartment of Psychiatry, University of Vermont Larner College of Medicine, Burlington, VT, USA.
Tobias BanaschewskiDepartment of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.ORCID 0000-0003-4595-1144
Arun L W BokdeDiscipline of Psychiatry, School of Medicine and Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland.ORCID 0000-0003-0114-4914
Sylvane DesrivièresCentre for Population Neuroscience and Precision Medicine (PONS), Institute of Psychiatry, Psychology & Neuroscience, SGDP Centre, King's College London, London, UK.ORCID 0000-0002-9120-7060
Herta FlorInstitute of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Square J5, Mannheim, Germany.
Antoine GrigisNeuroSpin, CEA, Université Paris-Saclay, F-91191, Gif-sur-Yvette, France.
Penny GowlandSir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, UK.ORCID 0000-0002-4900-4817
Andreas HeinzDepartment of Psychiatry and Psychotherapy Campus Charité Mitte, Charité-Universitätsmedizin, corporate member of Freie Universität Berlin & Humboldt-Universität zu Berlin, Berlin, Germany.ORCID 0000-0001-5405-9065
Rüdiger BrühlPhysikalisch-Technische Bundesanstalt (PTB), Braunschweig and Berlin, Braunschweig, Germany.ORCID 0000-0003-0111-5996
Jean-Luc MartinotInstitut National de la Santé et de la Recherche Médicale, INSERM U A10 "Trajectoires développementales en psychiatrie"; Université Paris-Saclay, Ecole Normale supérieure Paris-Saclay, CNRS, Centre Borelli, Gif-sur-Yvette, France.ORCID 0000-0002-0136-0388
Marie-Laure Paillère MartinotInstitut National de la Santé et de la Recherce Médicale, INSERM U A10 "Trajectoires développementales & psychiatrie", University Paris-Saclay, Ecole Normale Supérieure Paris-Saclay, CNRS; Centre Borelli, Gif-sur-Yvette, France.
Eric ArtigesInstitut National de la Santé et de la Recherche Médicale, INSERM U1299 "Trajectoires développementales en psychiatrie"; Ecole Normale supérieure Paris-Saclay, Université Paris-Saclay, Université de Paris, Centre Borelli; Gif-sur-Yvette, & Department of Psychiatry, EPS Barthélémy Durand, Etampes, France.ORCID 0000-0003-4461-7646
Frauke NeesDepartment of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.ORCID 0000-0002-7796-8234
Dimitri Papadopoulos OrfanosNeuroSpin, CEA, Université Paris-Saclay, F-91191, Gif-sur-Yvette, France.ORCID 0000-0002-1242-8990
Herve LemaitreNeuroSpin, CEA, Université Paris-Saclay, F-91191, Gif-sur-Yvette, France.
Tomáš PausDepartments of Psychiatry and Neuroscience, Faculty of Medicine and Centre Hospitalier Universitaire Sainte-Justine, University of Montreal, Montreal, QC, Canada.ORCID 0000-0003-1495-9338
Luise PoustkaDepartment of Child and Adolescent Psychiatry and Psychotherapy, University Medical Centre Göttingen, von-Siebold-Str. 5, 37075, Göttingen, Germany.
Sabina MillenetDepartment of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Juliane H FröhnerDepartment of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany.ORCID 0000-0002-8493-6396
Michael N SmolkaDepartment of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany.ORCID 0000-0001-5398-5569
Henrik WalterDepartment of Psychiatry and Psychotherapy Campus Charité Mitte, Charité-Universitätsmedizin, corporate member of Freie Universität Berlin & Humboldt-Universität zu Berlin, Berlin, Germany.ORCID 0000-0002-9403-6121
Robert WhelanSchool of Psychology and Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland.ORCID 0000-0002-2790-7281
Scott MackeyDepartment of Psychiatry, University of Vermont Larner College of Medicine, Burlington, VT, USA.
Gunter SchumannCentre for Population Neuroscience and Stratified Medicine (PONS), Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0002-7740-6469
Hugh GaravanDepartment of Psychiatry, University of Vermont Larner College of Medicine, Burlington, VT, USA.
IMAGEN Consortium
University of Vermont · USHeidelberg University · DECentre National de la Recherche Scientifique · FRCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRHumboldt-Universität zu Berlin · DETechnische Universität Dresden · DETrinity College Dublin · IEKing's College London · GBFudan University · CNInserm · FRPhysikalisch-Technische Bundesanstalt · DEUniversity of Göttingen · DEUniversity of Mannheim · DEUniversity of Nottingham · GBUniversity of Toronto · CAÉcole Normale Supérieure Paris-Saclay · FRInstitut de Recherche en Informatique et Systèmes Aléatoires · FRLaureate Institute for Brain Research · US

Funding

Training U54EB020403 · NIBIB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI THOMPSON, PAUL M · 2014 to 2018
$10.1M
ENIGMA- Addiction: Pooling of Existing Datasets to Identify Brain and Genetic Correlates of Addiction, Next StepsR01DA047119 · NIDA · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI HUGH P. GARAVAN · 2018 to 2026
$5.4M
A decentralized macro and micro gene-by-environment interaction analysis of substance use behavior and its brain biomarkers R01DA049238 · NIDA · GEORGIA STATE UNIVERSITY · PI CALHOUN, VINCE D, LIU, JINGYU · 2019 to 2023
$2.9M
Axon, Testosterone and Mental Health during AdolescenceR01MH085772 · NIMH · BAYCREST CENTRE FOR GERIATRIC CARE · PI PAUS, TOMAS · 2010 to 2014
$1.5M
Training in Complex Systems and Data Science Approaches Applied to the Neurobiology of Drug UseT32DA043593 · NIDA · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI DODDS, PETER S., GARAVAN, HUGH P. · 2018 to 2022
$1.2M
Development and clinical validation of multimodal risk algorithms for predicting future internalizing psychopathologyK08MH121654 · NIMH · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI ALBAUGH, MATTHEW D · 2020 to 2023
$737k
ENIGMA World Aging CenterR56AG058854 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI THOMPSON, PAUL M · 2018 to 2018
$683k
Department of Health PR-ST-0416-10001Medical Research Council MR/N000390/1Medical Research Council MR/R00465X/1Medical Research Council MR/S020306/1MRF_ MRF-058-0004-RG-DESRIMRF_ MRF-058-0009-RG-DESR-C0759NIA NIH HHS R56 AG058854NIBIB NIH HHS U54 EB020403NIDA NIH HHS R01 DA047119NIDA NIH HHS R01 DA049238NIDA NIH HHS T32 DA043593NIMH NIH HHS K08 MH121654NIMH NIH HHS K08 MH121654-01A1NIMH NIH HHS R01 MH085772
6 · The paper itself

Abstract

While there is substantial evidence that cannabis use is associated with differences in human brain development, most of this evidence is correlational in nature. Bayesian causal network (BCN) modeling attempts to identify probable causal relationships in correlational data using conditional probabilities to estimate directional associations between a set of interrelated variables. In this study, we employed BCN modeling in 637 adolescents from the IMAGEN study who were cannabis naïve at age 14 to provide evidence that the accelerated prefrontal cortical thinning found previously in adolescent cannabis users by Albaugh et al. [1] is a result of cannabis use causally affecting neurodevelopment. BCNs incorporated data on cannabis use, prefrontal cortical thickness, and other factors related to both brain development and cannabis use, including demographics, psychopathology, childhood adversity, and other substance use. All BCN algorithms strongly suggested a directional relationship from adolescent cannabis use to accelerated cortical thinning. While BCN modeling alone does not prove a causal relationship, these results are consistent with a body of animal and human research suggesting that adolescent cannabis use adversely affects brain development.

Indexed as

CannabisHallucinogensSubstance-Related DisordersAdolescentBayes TheoremCerebral Cortical ThinningHumansHallucinogens

Identifiers

PMID35523763
PMCPMC9076659
OpenAlexW4229039000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.